Transdisciplinary Awards Program in Translational Medicine and Therapeutics (TAPITMAT)

Guidelines

• TAPITMAT grants are available to registered members of the Institute for Translational Medicine and Therapeutics (ITMAT) as well as Associate Members who hold Instructor A or Research Associate positions.

• We will offer the Hwang Transdisciplinary Award in Translational Medicine and Therapeutics during this funding cycle. This award will favor an application with particular potential for commercialization.

• Proposal must have at least two Co-Principal Investigators, ideally from different disciplines within the University of Pennsylvania, and at least one Co-Principal Investigator must have a primary appointment in the School of Medicine. Novel collaborative applications between faculty located in distinct schools in Penn are encouraged.

• The proposals must center on the translational space – from proof of concept in cells or model systems through to mechanistic studies in humans elucidating human physiology or mechanisms of disease or, in drug development, parsing sources of variability in drug response and/or dose selection in Phase II. Programs that plan to progress within that space and which deploy technologies and approaches conventionally segregated from each other within the traditional boundaries of academic medicine will be especially favored.

• Proposals that focus on translational therapeutics or on bridging the pediatric to adult divide are particularly encouraged.

• All proposals are due by December 8, 2017 at noon for a project start date of February 1, 2018.

LATE SUBMISSIONS WILL NOT BE ACCEPTED NOR, WILL EXTENSIONS BE GRANTED.

Application or Funding Questions Please direct any questions to Jessica German, bickhart@mail.med.upenn.edu or Jason Molli, molli@upenn.edu.